Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1124 of 5804
-
Could a new anesthesia method help very underweight lung transplant patients breathe on their own after surgery?
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm clinical study is to learn whether a spontaneous breathing-preserving perioperative management strategy can improve recovery and is safe in lung transplant recipients with very low body weight (body mass index \[BMI\] \<16 kg/…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New injectable HIV prevention program aims to protect latine communities
Prevention Recruiting nowThe purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persi…
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Can a smartphone app keep sickle cell patients out of the ER?
Disease control Recruiting nowIn a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing SCD-specific guidelines through an mHealth application with booklets will decrease acute healthcare u…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Community program aims to cut HIV risk in latino gay men
Prevention Recruiting nowThe goal of this quasi-experimental, community intervention is to reduce HIV sexual risk among Latino immigrant bisexual men or men who have sex with men. The main questions the study aims to answer are: Does the intervention improve sexual risk behaviors? Does the intervention …
Phase: NA • Sponsor: San Francisco State University • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New drug aims to speed platelet recovery in stem cell transplant patients
Disease control Recruiting nowThis study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematolo…
Phase: NA • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Surgeons tailor Stent-Grafts to fix aortic aneurysms in new trial
Disease control Recruiting nowThe purpose of this study is to see if physician modified endovascular grafts (PMEG) can be used safely for the treatment of aortic disorders. The surgeon will modify a commercially available graft tailored to the participant's anatomy for surgery. The researchers will follow par…
Phase: NA • Sponsor: Chandler Long, MD • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Broccoli vs. bladder cancer: could your diet keep tumors away?
Disease control Recruiting nowThis phase II trial is being done to develop and test a healthy eating program to reduce cancer recurrence (cancer that has come back after a period of improvement) and/or progression (cancer that is growing, spreading, or getting worse) in patients with non-muscle invasive bladd…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New cholesterol drug SHR-1918 enters final testing phase
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of SHR-1918 in reducing serum low-density lipoprotein cholesterol (LDL-C) and total triglycerides (TG) in patients with hyperlipidemia compared with placebo, and also includes To evaluate the effectiveness of SHR-1…
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Smartwatch AI could spot hidden heart condition
Diagnosis OngoingAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia affecting over one million people in the UK. It is associated with increased cardiovascular morbidity and mortality and costs the NHS between £1.4 billion and 2.5 billion annually. Current methods to detect AF incl…
Sponsor: Royal Brompton & Harefield NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
New hope for advanced breast cancer: experimental drug targets resistant tumors
Disease control Recruiting nowThis is a first-in-human, Phase Ia/Ib, dose-escalation and expansion study evaluating the safety, pharmacokinetics, and activity of GDC-0587 (cyclin-dependent kinase-4 \[CDK4\] inhibitor) as a monotherapy and in combination with giredestrant in participants with locally advanced …
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New radiotherapy technique aims to cut prostate cancer treatment side effects
Symptom relief Recruiting nowThis prospective clinical study compares patient-reported outcome measures (PROMs) after adaptive or conventional radiotherapy in prostate cancer. Adaptive radiotherapy (ART) aims to reduce uncertainties related to daily anatomical variations, thereby improving treatment accuracy…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Experimental CAR T-Cell therapy takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis FTiH, single-arm, open-label, investigator-initiated Phase I trial will evaluate the safety, antitumour activity, CK/pharmacodynamics (PD), biomarkers, immunogenicity, and feasibility of A-CAR032 in adult participants with mCRPC, who have previously progressed after ARPI tre…
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to help kidney patients fight acid and stay strong
Disease control Recruiting nowThe purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
Phase: PHASE3 • Sponsor: Renibus Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could vinegar and fasting fix prediabetes cholesterol?
Disease control CompletedA common metabolic abnormality in hyperglycemic individuals, dyslipidemia is strongly linked to an increased risk of cardiovascular illness. This study looked at how date cider vinegar and 5:2 intermittent fasting affected the lipid profile and metabolic indices of hyperglycemic …
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New scan may spot brain tumor recurrence without surgery
Diagnosis Recruiting nowThis clinical trial evaluates whether gallium-68 (Ga-68) prostate specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed tomography (CT) imaging is useful in differentiating between disease that has come back after a period of improvement (recurrence) or …
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Seaweed shield: spirulina derivative tested to stop radiation burns in throat
Prevention Not yet recruitingTo evaluate the efficacy and safety of a Spirulina-derived product in preventing and treating radiation-induced esophagitis in esophageal cancer patients undergoing intensity-modulated radiotherapy (IMRT).
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
Teens teaching teens: new program aims to prevent cancer through HPV vaccination
Prevention ENROLLING_BY_INVITATIONSchool-based health centers (SBHCs) are an important setting to improve health through detecting, managing and preventing chronic illness. Too few people are educated about the human papillomavirus (HPV), which can prevent tens of thousands of deaths from cancer each year. PEER w…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Light-Based scanner could help surgeons remove all cancer in one go
Diagnosis Recruiting nowThis analytical performance study aims to validate the SPCTRone system for use in breast conserving surgery of breast cancer patients. By collecting spectral biomarkers and correlating these with the golden standard of histopathological assessment by a pathologist, we aim to trai…
Sponsor: SPCTR • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Turmeric and blue light may heal blisters in rare skin disease
Symptom relief OngoingEpidermolysis bullosa (EB) is a rare condition that causes extreme fragility of the skin and mucous membranes, leading to the formation of painful blisters. It can be hereditary (HEB) or autoimmune (AEB), and its diagnosis requires invasive procedures such as biopsies. Saliva eme…
Phase: PHASE4 • Sponsor: Universidade Ceuma • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New hope for tough cancers: experimental drug VIB305 enters human trials
Disease control Recruiting nowThis clinical trial is an open-label, single-arm, non-randomized, dose-escalation and dose-expansion study targeting subjects with unresectable, advanced, malignant solid tumors who have failed or are unsuitable for standard treatments or refused the existing treatments. This st…
Phase: PHASE1, PHASE2 • Sponsor: Vibrant Sciences Limited • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC